Carcinoma, non-small-cell lung cancer (NSCLC)
Clinical trials for Carcinoma, non-small-cell lung cancer (NSCLC) explained in plain language.
Never miss a new study
Get alerted when new Carcinoma, non-small-cell lung cancer (NSCLC) trials appear
Sign up with your email to follow new studies for Carcinoma, non-small-cell lung cancer (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New chemo formula aims to keep lung cancer away after surgery
Disease control Recruiting nowThis study tests a drug called SMS001, a new version of the chemotherapy paclitaxel, in 42 people with non-small cell lung cancer (stages Ib to IIIa). The goal is to see if a single dose after surgery can safely prevent the cancer from coming back. Researchers will monitor side e…
Matched conditions: CARCINOMA, NON-SMALL-CELL LUNG CANCER (NSCLC)
Phase 2 • Sponsor: ToLymph Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New drug combo aims to shrink lung tumors enough for surgery
Disease control Recruiting nowThis phase II trial tests whether a new drug called IBI363, combined with standard chemotherapy, can shrink stage III non-small cell lung cancer that was initially too advanced to remove with surgery. The goal is to make the tumors operable, then remove them. About 43 adults with…
Matched conditions: CARCINOMA, NON-SMALL-CELL LUNG CANCER (NSCLC)
Phase 2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC